![An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-021-00157-6/MediaObjects/42466_2021_157_Fig2_HTML.png)
An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text
![The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients](https://scielo.isciii.es/img/revistas/pharmacy/v16n4//1885-642X-pharmpract-16-04-1220-g001.jpg)
The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients
![Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide - Schade - 2020 - Movement Disorders Clinical Practice - Wiley Online Library Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide - Schade - 2020 - Movement Disorders Clinical Practice - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/effdda5b-ba35-4dde-8fe8-0a5e4fa99fde/mdc3.v7.3.cover.jpg?trick=1673552937403)
Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide - Schade - 2020 - Movement Disorders Clinical Practice - Wiley Online Library
![Comparison of Antiparkinsonian Medication Initiation and Levodopa-Equivalent Daily Dose Across PPMI, STEADY-PD III, and SURE-PD3 - MDS Abstracts Comparison of Antiparkinsonian Medication Initiation and Levodopa-Equivalent Daily Dose Across PPMI, STEADY-PD III, and SURE-PD3 - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2021/09/0528_0752_001553_003.png)
Comparison of Antiparkinsonian Medication Initiation and Levodopa-Equivalent Daily Dose Across PPMI, STEADY-PD III, and SURE-PD3 - MDS Abstracts
![An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs42466-021-00157-6/MediaObjects/42466_2021_157_Fig1_HTML.png)
An updated calculator for determining levodopa-equivalent dose | Neurological Research and Practice | Full Text
![PDF] The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients | Semantic Scholar PDF] The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6d41f362dc7966910bafe4967d3ff5ce6db0d400/2-Table2-1.png)
PDF] The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients | Semantic Scholar
![Frontiers | Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan Frontiers | Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan](https://www.frontiersin.org/files/Articles/423919/fneur-10-00340-HTML/image_m/fneur-10-00340-t002.jpg)
Frontiers | Anxiety and Levodopa Equivalent Daily Dose Are Potential Predictors of Sleep Quality in Patients With Parkinson Disease in Taiwan
![The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients](https://www.redalyc.org/journal/690/69060005003/t2.png)
The effect of pramipexole extended release on the levodopa equivalent daily dose in Lebanese Parkinson diseased patients
![Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone](https://neurologyindia.com/articles/2017/65/4/images/ni_2017_65_4_746_209533_t4.jpg)
Levodopa dose maintenance or reduction in patients with Parkinson's disease transitioning to levodopa/carbidopa/entacapone
No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial | PLOS ONE
![Comparison of Antiparkinsonian Medication Initiation and Levodopa-Equivalent Daily Dose Across PPMI, STEADY-PD III, and SURE-PD3 - MDS Abstracts Comparison of Antiparkinsonian Medication Initiation and Levodopa-Equivalent Daily Dose Across PPMI, STEADY-PD III, and SURE-PD3 - MDS Abstracts](https://www.mdsabstracts.org/wp-content/uploads/2021/09/0528_0752_001553_001.png)